ReviewNature reviews. Rheumatology2019
The role of imaging in the diagnosis and management of axial spondyloarthritis.
Review in Nature reviews. Rheumatology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
36 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Upadacitinib for axial spondyloarthritis: a meta-analysis of efficacy and safety.Clinical rheumatology · 2024Pooled it
- The correlations between C-reactive protein and MRI-detected inflammation in patients with axial spondyloarthritis: a systematic review and meta-analysis.Clinical rheumatology · 2023Pooled it
- Phase II randomised, placebo-controlled study to evaluate the efficacy and safety of an MK2 inhibitor in ankylosing spondylitis.RMD open · 2026Trial
- Validation of SPARCC MRI-RETIC e-tools for increasing scoring proficiency of MRI sacroiliac joint lesions in axial spondyloarthritisRMD open · 2024Trial
- Can radiomics replace the SPARCC scoring system in evaluating bone marrow edema of sacroiliac joints in patients with axial spondyloarthritis?Clinical rheumatology · 2023Trial
- Challenges in diagnosing and monitoring radiographic and non-radiographic axial spondyloarthritis in daily clinical practice.Clinical rheumatology · 2026Article
- Sex and gender differences in rheumatology: clinical impact and future directions.Nature reviews. Rheumatology · 2026Review
- Time-efficient MRI scoring system for axial spondyloarthritis: a feasibility study.European radiology · 2026Article
- Article
- Comprehensive overview of alternative medicine in the treatment of ankylosing spondylitis: Symptoms, pathogenesis, diagnosis and treatments (Review).Biomedical reports · 2026Review
- Erosive costovertebral joint arthritis as a novel feature of ankylosing spondylitis.Quantitative imaging in medicine and surgery · 2025Article
- Recent advances and insights into imaging of axial spondyloarthritis.Skeletal radiology · 2025Review
- Current and future role of CT and advanced CT applications in inflammatory arthritis in the clinic and trials.Skeletal radiology · 2025Review
- [Spondylitis and spondylodiscitis].Radiologie (Heidelberg, Germany) · 2025Review
- Article
- Global Functioning in Axial Spondyloarthritis is Stronger Associated With Disease Activity and Function Than With Mobility and Radiographic Damage.Arthritis care & research · 2025Article
- Profiling of IgG N-glycosylation for axial spondyloarthritis and other rheumatic diseases.Arthritis research & therapy · 2025Article
- Axial Imaging in Spondyloarthritis.Rheumatic diseases clinics of North America · 2024Review
- Artificial intelligence improves the diagnosis of human leukocyte antigen (HLA)-B27-negative axial spondyloarthritis based on multi-sequence magnetic resonance imaging and clinical features.Quantitative imaging in medicine and surgery · 2024Article
- The bone marrow side of axial spondyloarthritis.Nature reviews. Rheumatology · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
MRI of the sacroiliac joints is increasingly acknowledged as being indispensable in the early diagnosis of axial spondyloarthritis (axSpA) and as having a prominent role in the prognosis and classification of axSpA. Technological advances include improvements in the resolution of structural lesions and in methodologies for the quantification of lesions. Limited access and expertise in interpretation of MRI have led to a resurgence of interest in CT, especially the development of low radiation protocols for assessing the sacroiliac joints. Trials of TNF inhibitors in patients with non-radiographic axSpA have led to greater understanding of the role of MRI in selecting which patients might respond well to this therapy. The role of MRI features as target end points in treat-to-target strategies remains unclear because the effect of such targeting on structural damage parameters has only recently been explored. The relative importance of active and structural lesions for prognostic risk assessment and selection of appropriate treatment is also an area of current research. Given the increased capacity to visualize a broad array of lesions in both the sacroiliac joints and the spine using MRI and CT, these modalities will probably be increasingly employed for assessment of the disease-modifying activity of new therapies.
Indexed as
Identifiers
31591500What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.